tiprankstipranks
Algernon Pharmaceuticals (AGNPF)
OTHER OTC:AGNPF
Holding AGNPF?
Track your performance easily

Algernon Pharmaceuticals (AGNPF) Financial Statements

71 Followers

Algernon Pharmaceuticals Financial Overview

Algernon Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-0.134; its P/E ratio is -0.30; Algernon Pharmaceuticals is scheduled to report earnings on January 23, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
May 24Feb 24Nov 23Aug 23May 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBITC$ 1.44MC$ -1.00MC$ -521.55KC$ -2.53MC$ -1.13M
EBITDAC$ 1.44MC$ -1.00MC$ -514.13KC$ -2.51MC$ -1.13M
Net Income Common StockholdersC$ 1.44MC$ -1.00MC$ -521.55KC$ -2.53MC$ -1.13M
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 609.52KC$ 76.28KC$ 74.17KC$ 125.08KC$ 434.23K
Total AssetsC$ 3.89MC$ 3.95MC$ 3.95MC$ 4.19MC$ 6.14M
Total DebtC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Net DebtC$ -609.52KC$ -76.28KC$ -74.17KC$ -125.08KC$ -434.23K
Total LiabilitiesC$ 1.93MC$ 3.52MC$ 2.94MC$ 2.72MC$ 2.41M
Stockholders EquityC$ 1.96MC$ 437.32KC$ 1.01MC$ 1.47MC$ 3.72M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow--C$ -52.24K--
Investing Cash Flow-----
Financing Cash Flow-----
Currency in CAD

Algernon Pharmaceuticals Earnings and Revenue History

Algernon Pharmaceuticals Debt to Assets

Algernon Pharmaceuticals Cash Flow

Algernon Pharmaceuticals Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis